[REGN] YoY Quarter Result on 30-Sep-2010 [#Q3]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
28-Oct-2010
Financial Year
2010
Quarter
30-Sep-2010 [#Q3]
Profit Trend
QoQ- -32.98%
YoY- -3,237.44%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
Revenue 597,027 427,687 102,833 105,979 117,455 65,584 22,311 72.86%
PBT 225,684 191,468 -61,803 -31,641 -1,015 -18,036 -32,827 -
Tax 84,378 -517 562 -906 -857 3,079 -8,669 -
NP 141,306 191,468 -62,365 -33,875 -1,015 -21,115 -35,838 -
Tax Rate -37.39% 0.27% - - - - - -
Total Cost 455,721 236,219 165,198 139,854 118,470 86,699 58,149 40.89%
Ratio Analysis
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
NP Margin 23.67 44.77 -60.65 -31.96 -0.86 -32.20 -160.63 -
Per Share
30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 CAGR
EPS 1.44 2.02 -0.68 -0.41 -0.01 -0.27 -0.54 -
EPS Diluted 1.25 1.72 -0.68 -0.41 -0.01 -0.27 -0.54 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.